Putting Out the Fire before it becomes an Inferno: Responding to an Outbreak of Diphtheria in Edo State, Nigeria

Main Article Content

Ayebo Evawere Sadoh
Iriagbonse Iyabo Osaigbovo
Ekiye Ayinbuomwan
Esohe Ogboghodo
Amina Okhakhu
Osahon Osaghae
Sunday Adanas
Cynthia Eigbe
Emmanuel Okoeguale
Samuel Adebudo
Mbalya Jude Rabo
Isaac Igbarumah
Blessing Aideyan
Stevenson Ojeifo
Nora Eyo

Keywords

Abstract

Background: The recent outbreak of diphtheria in Nigeria, lasting over 18 months, is largely attributed to a lack of vaccination, but other factors may have been contributory. The study aims to describe the characteristics of cases and control measures of a localised outbreak of diphtheria in Edo State, Nigeria.


Methodology: This was a descriptive study of patients who met the case definition for suspected diphtheria in Edo state between May and September 2024. A multidisciplinary management strategy was instituted for sample collection, integrated disease surveillance, contact investigation, awareness creation and standard treatment protocols. Data (age, gender, immunization status, signs and symptoms, receipt of Diphtheria Antitoxin (DAT), laboratory results and outcomes) were extracted from the case notes, entered into an Excel spreadsheet and exported into an SPSS spreadsheet for analysis. Continuous data were expressed as median (IQR), categorical data were summarized as proportions, and the level of immunity was categorized into adequate and inadequate. Ethical approval for the study was obtained from the University of Benin Health Research Ethics Committee with Protocol Number: ADM/22/A/VOL.VII/4831141825 and dated May 28th 2025


Results: Of the19 suspected cases, 5(26.3%) were laboratory confirmed, and 4/5(80.0%) of the confirmed cases were older than 9 years. The commonest symptoms were catarrh12(63.2%), sore throat and neck swelling  11(57.9%) each, and fever and hoarseness 10(52.6%). The majority, 89.6% were vaccinated. Of the ten cases that had serology done, 7(70%) had inadequate immunity. No secondary cases were found on contact investigation.


Conclusion: A multidisciplinary team approach ensured this outbreak did not spread widely.  With diphtheria occurring in almost 90% of previously vaccinated children, waned immunity was likely a major contributor to this outbreak. It is recommended that booster doses be included in the immunization schedule of Nigerian children.

Abstract 204 | PDF Downloads 66 EPUB Downloads 41

References

1. Lo BM. Diphtheria. Emedicine. Available at https://emedicine.medscape.com/articale/782051-overview. Accessed 26th February 2023
2. Vitek CR. Diphtheria. Curr Top Microbiol Immunol. 2006;304:71-94. doi: 10.1007/3-540-36583-4_5. PMID: 16989265.
3. Sadoh AE, Oladokun RE. Re-emergence of diphtheria and pertussis: Implications for Nigeria. Vaccine 2012;30:7221-28
4. World Health Organization. Diphtheria vaccine: WHO position paper- August 2017. Weekly Epidemiological Record 2017;92:417-436
5. World Health Organization. Global health observatory data repository. Available at https://apps.who.int/gho/data/view.main.1540_41?lang=en
6. Sadoh AE, Okhakhu A, Omuemu V, Lofor PV, Oviawe O. Diphtheria in Nigeria: Is there resurgence? Ann Biomed Sci 2009;8:66-74
7. Besa NC, Coldiron ME, Barki A, Raji A, Nsuami MJ, Rousseau C et al. Diphtheria outbreak with high mortality in north eastern Nigeria. Epidemiol Infect 2014;142:797-802
8. Nigeria Centre for Disease Control and Prevention. Diphtheria situation report. Available at https://www.ncdc.gov.ng/diseases/sitreps/?cat=
9. Abdulrasheed N, Lawali L, Mogagi AB, Abdulkareem AO, Shuaib AK, Adeoti SG et al. Recurrent diphtheria outbreaks in Nigeria: A review of the underlying factors and remedies. Immunity, Inflammation and Disease 2023; DOI: 10.1002/iid3.1096
10. World Health Organisation. Diphtheria: vaccine preventable diseases surveillance standard. WHO 2018. Available at https://cdn.who.int/media/docs/default-source/immunization/vpd_surveillance/vpd-surveillance-standards-publication/who-surveillancevaccinepreventable-04-diphtheria-r2.pdf?sfvrsn=3840f49a_10&download=true Accessed February 14th 2025
11. World Health Organization. Clinical management of diphtheria: guideline, 2 February 2024. Geneva: World Health Organi¬zation; 2024 (WHO/DIPH/Clinical/2024.1). Licence: CC BY-NC-SA 3.0 IGO.
12. Yusoff AF, Sharani ZZM, Chong KC, Mdlderus NH, Zamri ASS, Nagalingam T et al. Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population. BMC Infect Dis 2021;21:581
13. Alege A, Ibrahim OR, Ibraheem RM, Aladesua O, Lugga A, Yahaya YY et al. Clinical presentation and predictors of hospital mortality of diphtheria in Nigeria, July 2023 to April 2024: a single-center study. BMC Infect Dis 2025; 25:8 Available at https://doi.org/10.1186/s12879-024-10401-4
14. Denue A, Ngoshe RM, Abdul H, Akawu CB, Gana ML, Hussaini AY et al. Clinical presentation and outcome of diphtheria in health facility in North-East Nigeria The Egyptian Journal of Internal Medicine https://doi.org/10.1186/s43162-024-00372-
15. Federal Ministry of Health and Social Welfare Abuja, Nigeria National Population Commission Abuja, Nigeria The DHS Program ICF Rockville, Maryland, USA. Nigeria Demographic and Health Survey 2023-2024 key indicators report September 2023
16. Smith P. Concepts of herd protection and immunity. Procedia in Vaccinology 2010;2:134-9

Most read articles by the same author(s)